Published in Bioorg Med Chem Lett on September 19, 2009
Developing β-secretase inhibitors for treatment of Alzheimer's disease. J Neurochem (2011) 1.37
β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med (2012) 1.05
Strong nonadditivity as a key structure-activity relationship feature: distinguishing structural changes from assay artifacts. J Chem Inf Model (2015) 0.80
Design and Synthesis of Novel Arylketo-containing P1-P3 Linked Macro-cyclic BACE-1 Inhibitors. Open Med Chem J (2015) 0.75
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem (2006) 4.06
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res (2003) 3.47
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice. J Biol Chem (2007) 2.22
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A (2010) 1.65
Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function. J Am Chem Soc (2008) 1.52
Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core. Org Lett (2005) 1.51
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther (2002) 1.43
Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol (2011) 1.42
Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation. Org Lett (2005) 1.40
Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem (2011) 1.29
Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol (2004) 1.24
Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters. Org Lett (2009) 1.20
Crystal structure of the first KH domain of human poly(C)-binding protein-2 in complex with a C-rich strand of human telomeric DNA at 1.7 A. J Biol Chem (2005) 1.19
BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease. Neurobiol Aging (2007) 1.17
Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat Med (2011) 1.10
On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions of alpha-synuclein with Congo red and lacmoid. Biochemistry (2009) 1.07
A formal synthesis of (-)-mycalamide A. J Am Chem Soc (2004) 1.05
LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse. J Immunol (2007) 1.03
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2003) 1.03
Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells. J Biol Chem (2003) 1.01
Human beta-secretase (BACE) and BACE inhibitors. J Med Chem (2003) 1.00
TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol (2010) 0.99
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension (2009) 0.99
Significant caval penetration by the celect inferior vena cava filter: attributable to filter design? J Vasc Interv Radiol (2007) 0.97
Pharmacological induction of neuroglobin expression. Pharmacology (2011) 0.97
Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription. J Immunol (2006) 0.96
The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance. Curr Pharm Des (2007) 0.96
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites. Clin Pharmacol Ther (2003) 0.96
Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes (2011) 0.96
Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group. J Med Chem (2007) 0.95
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans. J Neurol Neurosurg Psychiatry (2012) 0.95
Signals and sequences that control CD28 localization to the central region of the immunological synapse. J Immunol (2008) 0.94
Hunter-killer peptide (HKP) for targeted therapy. J Med Chem (2008) 0.94
Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J Clin Pharmacol (2002) 0.94
Alternative approaches to control--quo vadit? Vet Parasitol (2006) 0.94
Development of a rapid quantitative PCR assay for direct detection and quantification of culturable and non-culturable Escherichia coli from agriculture watersheds. J Microbiol Methods (2007) 0.93
The identification and optimization of orally efficacious, small molecule VLA-4 antagonists. Curr Top Med Chem (2004) 0.93
Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase. J Med Chem (2007) 0.92
Next generation therapeutics for Alzheimer's disease. EMBO Mol Med (2013) 0.91
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease. Alzheimers Res Ther (2010) 0.91
Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors. Bioorg Med Chem Lett (2009) 0.91
Antinociceptive and anti-inflammatory activities of Phlomis umbrosa Turcz extract. Fitoterapia (2011) 0.90
Importance of the caspase cleavage site in amyloid-β protein precursor. J Alzheimers Dis (2010) 0.90
Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci U S A (2013) 0.89
Acaricidal activity of extracts from Adonis coerulea Maxim. against Psoroptes cuniculi in vitro and in vivo. Vet Parasitol (2013) 0.88
Design of substrate-based inhibitors of human beta-secretase. J Med Chem (2002) 0.87
Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide. J Chem Phys (2013) 0.87
Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce α-synuclein phosphorylation in rat brain. ChemMedChem (2013) 0.87
A methods comparison for the isolation and detection of thermophilic Campylobacter in agricultural watersheds. J Microbiol Methods (2009) 0.86
Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase. J Med Chem (2004) 0.86
Endoluminal dilation technique to remove "stuck" tunneled hemodialysis catheters. J Vasc Interv Radiol (2012) 0.85
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor. Bioorg Med Chem Lett (2011) 0.85
Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors. Antimicrob Agents Chemother (2002) 0.85
Directed reduction of beta-amino ketones to syn or anti 1,3-amino alcohol derivatives. Org Lett (2002) 0.85
Heterobiaryl human immunodeficiency virus entry inhibitors. J Med Chem (2009) 0.84
Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors. Biochem Biophys Res Commun (2013) 0.84
Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog. Drug Metab Dispos (2003) 0.84
Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimers Res Ther (2012) 0.84